Effect of the Automatic Surveillance System on Surveillance Rate of Patients with Gastric Premalignant Lesions
Recruiting
N/A
Interventional Study
Artificial Intelligence
Surveillance
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 1,460 (estimated)
- Sponsor
- Renmin Hospital of Wuhan University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of patients with gastric premalignant lesions. The enrolled patients were divided into group A with intelligent surveillance system, group B with manual reminder, and group C with natural state. The surveillance among the three groups will be compared.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male or female aged 18 years or older who undergo upper endoscopy.
Exclusion Criteria:
* 1)No contact information or invalid contact information.
* 2\) The surveillance interval cannot be determined according to the surveillance guidelines, including no upper gastrointestina…
Contacts